Viewing Study NCT00807235

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2026-06-04 @ 8:51 PM
Study NCT ID: NCT00807235
Status: TERMINATED
Last Update Posted: 2012-06-13
First Post: 2008-12-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
Sponsor: Windtree Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Respiratory Distress Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lucinactant View
None Nasal continuous positive airway pressure (nCPAP) View
None Respiratory distress syndrome (RDS) View
None Pediatric View
None Premature View